Periodontal Therapeutics Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Feb 2021
  • Pages: 120
  • SKU: IRTNTR70188
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The periodontal therapeutics market share is expected to increase by USD 120.80 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 6%.

This periodontal therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by product (Local antibiotics and Systemic antibiotics) and geography (North America, Europe, Asia, and ROW). The periodontal therapeutics market report also offers information on several market vendors, including 3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd. among others.

What will the Periodontal Therapeutics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Periodontal Therapeutics Market Size for the Forecast Period and Other Important Statistics

 

Periodontal Therapeutics Market: Key Drivers and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The rising prevalence of periodontal diseases is notably driving the periodontal therapeutics market growth, although factors such as development of antibiotic resistant bacterial strain may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the periodontal therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Driver for the Periodontal Therapeutics Market

The rising prevalence of periodontal diseases is one of the key drivers for the market in focus. Periodontal are prevalent in both developed and developing countries and affect individuals irrespective of their age, thus, making them a public health concern. Periodontal diseases have evolved as the most common oral condition in human beings globally. With the rising global prevalence of periodontal diseases, there will be an increased demand for periodontal drugs, which will drive the market's growth during the forecast period. 

Key Periodontal Therapeutics Market Challenge

The development of antibiotic-resistant bacterial strains is one of the challenges for the market in focus. Patients with chronic periodontitis often yield various types of bacterial strains that may vary in their susceptibility toward antibiotic therapy. Several studies have been conducted to evaluate the susceptibility of selected subgingival periodontal pathogens toward antibiotics in patients with chronic periodontitis. Globally, antibiotic resistance among patients with chronic periodontitis is increasing at an alarming rate. Thus, making the antibiotic less effective in treating the diseases, thereby decreasing the use of antibiotics among these patients. The decreased consumption of antibiotics hinders the growth prospects of the market.

This periodontal therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Periodontal Therapeutics Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • 3M Co.
  • Bausch Health Companies Inc.
  • Cadila Healthcare Ltd.
  • Den-Mat Holdings LLC
  • Dexcel Pharma Technologies Ltd.
  • KAKEN PHARMACEUTICAL CO. LTD.
  • Pfizer Inc.
  • Straumann Holding AG
  • Sunstar Suisse SA
  • Teva Pharmaceutical Industries Ltd.

 

This statistical study of the periodontal therapeutics market encompasses successful business strategies deployed by the key vendors. The periodontal therapeutics market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The periodontal therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Periodontal Therapeutics Market?

For more insights on the market share of various regions Request for a FREE sample now!

40% of the market’s growth will originate from North America during the forecast period. The US is the key country for the periodontal therapeutics market in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increasing patient pool with periodontal diseases will facilitate the periodontal therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Periodontal Therapeutics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The periodontal therapeutics market share growth by the local antibiotics segment will be significant during the forecast period. The high market share is attributed to the increased use of local antibiotics for the treatment of periodontal diseases. These drugs offer targeted delivery, which increases the bioavailability of drugs and improves pharmacologic effects. The adoption of local antibiotics to achieve the desired response contributes to the growth of the segment. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the periodontal therapeutics market size and actionable market insights on post COVID-19 impact on each segment.

 

Periodontal Therapeutics Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 6%

Market growth 2021-2025

$ 120.80 million

Market structure

Fragmented

YoY growth (%)

6.01

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 40%

Key consumer countries

US, Germany, France, UK, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Periodontal Therapeutics Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive periodontal therapeutics market growth during the next five years
  • Precise estimation of the periodontal therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the periodontal therapeutics industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of periodontal therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • Local antibiotics - Market size and forecast 2020-2025
    • Systemic antibiotics - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

    • Customer landscape

    Geographic Landscape

    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends

    Vendor Landscape

    • Competitive scenario
    • Vendor landscape
    • Landscape disruption

    Vendor Analysis

    • Vendors covered
    • Market positioning of vendors
    • 3M Co.
    • Bausch Health Companies Inc.
    • Cadila Healthcare Ltd.
    • Den-Mat Holdings LLC
    • Dexcel Pharma Technologies Ltd.
    • KAKEN PHARMACEUTICAL CO. LTD.
    • Pfizer Inc.
    • Straumann Holding AG
    • Sunstar Suisse SA
    • Teva Pharmaceutical Industries Ltd.

    Appendix

    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

    Research Framework

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    TechnavioINFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases
    Technavio

    TechnavioDATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts
    Technavio

    TechnavioREPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape
    Interested in this report?
    Get your FREE sample now!
    The periodontal therapeutics market growth will increase by $120.80 million during 2020-2025.
    The periodontal therapeutics market is expected to grow at a CAGR of 6.45% during 2020-2025.
    Technavio has segmented the periodontal therapeutics market by product (Local antibiotics and Systemic antibiotics) and geographic (North America, Europe, Asia, and ROW).
    3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, Teva Pharmaceutical Industries Ltd. are a few of the key vendors in the periodontal therapeutics market.
    North America will register the highest growth rate of 40.26% among the other regions. Therefore, the periodontal therapeutics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
    The key factors driving the periodontal therapeutics market growth are:
    • Rising prevalence of periodontal diseases
    • Growing geriatric population
    The periodontal therapeutics market vendors should focus on grabbing business opportunities from the local antibiotics segment as it accounted for the largest market share in the base year.
    Safe and Secure SSL Encrypted
    Technavio

    Single User:

    2500 USD

    Technavio Get the report (PDF) sent to your email within minutes.

    Subscribe & Save

    Get lifetime access to our
    Technavio Insights

    Want to customize this report?

    This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

    We offer $1000 worth of FREE customization at the time of purchase
    Technavio
    Enquire Before Buying
    1. Home
    2. Health Care
    3. Published Report
    17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>